<PAGE>
===============================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________
AMENDMENT NO. 1
TO
FORM 10-Q
___________
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended June 30, 1995
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _______________ to _______________
Commission file number: 1-9988
REXENE CORPORATION
(Exact name of Registrant as Specified in its Charter)
DELAWARE 75-2104131
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
5005 LBJ FREEWAY
DALLAS, TEXAS 75244
(Address of principal executive offices) (Zip code)
(214) 450-9000
(Registrant's telephone number, including area code)
Indicate by check mark whether the Registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No
____ ____
APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the Registrant has filed all documents and
reports required to be filed by Section 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court. Yes X No
_____ ____
At July 24, 1995, 18,736,791 shares of common stock, par value $0.01 per
share, of Rexene Corporation were outstanding.
===============================================================================
<PAGE>
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits:
10.19 - 1995 Stock Option Plan for Outside Directors
27 - Financial Data Schedule
(b) Reports Submitted on Form 8-K:
None.
11
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
REXENE CORPORATION
Date: August 9, 1995 By: /s/ KEVIN W. McALEER
-------------------------------
Kevin W. McAleer
Executive Vice President and
Chief Financial Officer
12
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-START> APR-01-1995
<PERIOD-END> JUN-30-1995
<CASH> 21,621
<SECURITIES> 0
<RECEIVABLES> 82,511
<ALLOWANCES> 3,481
<INVENTORY> 67,690
<CURRENT-ASSETS> 175,265
<PP&E> 316,224
<DEPRECIATION> 46,310
<TOTAL-ASSETS> 483,433
<CURRENT-LIABILITIES> 66,358
<BONDS> 0
<COMMON> 187
0
0
<OTHER-SE> 119,177
<TOTAL-LIABILITY-AND-EQUITY> 483,433
<SALES> 159,452
<TOTAL-REVENUES> 159,452
<CGS> 107,168
<TOTAL-COSTS> 107,168
<OTHER-EXPENSES> 12,876
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 7,328
<INCOME-PRETAX> 32,784
<INCOME-TAX> 12,252
<INCOME-CONTINUING> 20,532
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 20,532
<EPS-PRIMARY> 1.07
<EPS-DILUTED> 1.07
</TABLE>
